These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

918 related articles for article (PubMed ID: 29882082)

  • 21. MRCIP: a robust Mendelian randomization method accounting for correlated and idiosyncratic pleiotropy.
    Xu S; Fung WK; Liu Z
    Brief Bioinform; 2021 Sep; 22(5):. PubMed ID: 33704372
    [TBL] [Abstract][Full Text] [Related]  

  • 22. A Bayesian approach to Mendelian randomization using summary statistics in the univariable and multivariable settings with correlated pleiotropy.
    Grant AJ; Burgess S
    Am J Hum Genet; 2024 Jan; 111(1):165-180. PubMed ID: 38181732
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Diagnostics for Pleiotropy in Mendelian Randomization Studies: Global and Individual Tests for Direct Effects.
    Dai JY; Peters U; Wang X; Kocarnik J; Chang-Claude J; Slattery ML; Chan A; Lemire M; Berndt SI; Casey G; Song M; Jenkins MA; Brenner H; Thrift AP; White E; Hsu L
    Am J Epidemiol; 2018 Dec; 187(12):2672-2680. PubMed ID: 30188971
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Weak-instrument robust tests in two-sample summary-data Mendelian randomization.
    Wang S; Kang H
    Biometrics; 2022 Dec; 78(4):1699-1713. PubMed ID: 34213007
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Mendelian randomisation for mediation analysis: current methods and challenges for implementation.
    Carter AR; Sanderson E; Hammerton G; Richmond RC; Davey Smith G; Heron J; Taylor AE; Davies NM; Howe LD
    Eur J Epidemiol; 2021 May; 36(5):465-478. PubMed ID: 33961203
    [TBL] [Abstract][Full Text] [Related]  

  • 26. An efficient and robust approach to Mendelian randomization with measured pleiotropic effects in a high-dimensional setting.
    Grant AJ; Burgess S
    Biostatistics; 2022 Apr; 23(2):609-625. PubMed ID: 33155035
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Causes of comorbidity: pleiotropy or causality? Shared genetic and environmental influences on migraine and neuroticism.
    Ligthart L; Boomsma DI
    Twin Res Hum Genet; 2012 Apr; 15(2):158-65. PubMed ID: 22856357
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Detection of widespread horizontal pleiotropy in causal relationships inferred from Mendelian randomization between complex traits and diseases.
    Verbanck M; Chen CY; Neale B; Do R
    Nat Genet; 2018 May; 50(5):693-698. PubMed ID: 29686387
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Improving the accuracy of two-sample summary-data Mendelian randomization: moving beyond the NOME assumption.
    Bowden J; Del Greco M F; Minelli C; Zhao Q; Lawlor DA; Sheehan NA; Thompson J; Davey Smith G
    Int J Epidemiol; 2019 Jun; 48(3):728-742. PubMed ID: 30561657
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Multivariable Mendelian randomization: the use of pleiotropic genetic variants to estimate causal effects.
    Burgess S; Thompson SG
    Am J Epidemiol; 2015 Feb; 181(4):251-60. PubMed ID: 25632051
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Exploiting horizontal pleiotropy to search for causal pathways within a Mendelian randomization framework.
    Cho Y; Haycock PC; Sanderson E; Gaunt TR; Zheng J; Morris AP; Davey Smith G; Hemani G
    Nat Commun; 2020 Feb; 11(1):1010. PubMed ID: 32081875
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Mendelian randomization mixed-scale treatment effect robust identification and estimation for causal inference.
    Liu Z; Ye T; Sun B; Schooling M; Tchetgen ET
    Biometrics; 2023 Sep; 79(3):2208-2219. PubMed ID: 35950778
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Testing and correcting for weak and pleiotropic instruments in two-sample multivariable Mendelian randomization.
    Sanderson E; Spiller W; Bowden J
    Stat Med; 2021 Nov; 40(25):5434-5452. PubMed ID: 34338327
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Mendelian randomization incorporating uncertainty about pleiotropy.
    Thompson JR; Minelli C; Bowden J; Del Greco FM; Gill D; Jones EM; Shapland CY; Sheehan NA
    Stat Med; 2017 Dec; 36(29):4627-4645. PubMed ID: 28850703
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Combining Mendelian randomization with the sibling comparison design.
    Sjölander A; Frisell T; Öberg S; Wang Y; Hägg S
    Stat Med; 2024 Feb; 43(4):731-755. PubMed ID: 38073579
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Assessing causal relationships using genetic proxies for exposures: an introduction to Mendelian randomization.
    Katikireddi SV; Green MJ; Taylor AE; Davey Smith G; Munafò MR
    Addiction; 2018 Apr; 113(4):764-774. PubMed ID: 28921935
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Detecting and correcting for bias in Mendelian randomization analyses using Gene-by-Environment interactions.
    Spiller W; Slichter D; Bowden J; Davey Smith G
    Int J Epidemiol; 2019 Jun; 48(3):702-712. PubMed ID: 30462199
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Genetic evidence for a large overlap and potential bidirectional causal effects between resilience and well-being.
    de Vries LP; Baselmans BML; Luykx JJ; de Zeeuw EL; Minică CC; de Geus EJC; Vinkers CH; Bartels M
    Neurobiol Stress; 2021 May; 14():100315. PubMed ID: 33816719
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Network Mendelian randomization: using genetic variants as instrumental variables to investigate mediation in causal pathways.
    Burgess S; Daniel RM; Butterworth AS; Thompson SG;
    Int J Epidemiol; 2015 Apr; 44(2):484-95. PubMed ID: 25150977
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Overlapping-sample Mendelian randomisation with multiple exposures: a Bayesian approach.
    Zou L; Guo H; Berzuini C
    BMC Med Res Methodol; 2020 Dec; 20(1):295. PubMed ID: 33287714
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 46.